Should You Buy Adaptive Biotechnologies Corp (ADPT) Today? Analysis, Price Targets, and 2026 Outlook.
No data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast ADPT stock price to rise
8 Analyst Rating
Wall Street analysts forecast ADPT stock price to rise
7 Buy
1 Hold
0 Sell
Strong Buy
Current: 13.810
Low
20
Averages
20.86
High
22
Current: 13.810
Low
20
Averages
20.86
High
22
JPMorgan
Overweight
downgrade
$21 -> $19
AI Analysis
2026-05-06
New
Reason
JPMorgan
Price Target
$21 -> $19
AI Analysis
2026-05-06
New
downgrade
Overweight
Reason
JPMorgan lowered the firm's price target on Adaptive Biotechnologies to $19 from $21 and keeps an Overweight rating on the shares. The firm updated the company's model post the Q1 report.
TD Cowen
Buy
maintain
$19 -> $21
2026-05-06
New
Reason
TD Cowen
Price Target
$19 -> $21
2026-05-06
New
maintain
Buy
Reason
TD Cowen raised the firm's price target on Adaptive Biotechnologies to $21 from $19 and keeps a Buy rating on the shares. The firm said the company delivered another nearly 50% year over year MRD growth quarter
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ADPT
